Alkem Laboratories has appointed Shirish Purushotham Ambulgekar at senior management position in the Company effective from 10 March 2025. Shirish Purushotham Ambulgekar has completed his Masters of ...

This is to inform you that Mr. Shirish Purushotham Ambulgekar has been appointed at the senior management position of the Company w.e.f. 10th March, 2025.

New Delhi: Alkem Laboratories has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the bioequivalance (BE) ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Mistral Solutions Private Ltd, (Mistral) a subsidiary of AXISCADES Technologies Limited (AXISCADES), a chip to product company and a pioneer in Defense, Electronics, Semiconductor and Artificial ...

Featured here, the Income Statement (earnings report) for Alkem Laboratories Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and ...

New Delhi: Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

According to the block deal data available on the National Stock Exchange (NSE), SBI Mutual Fund acquired 6.41 lakh shares or 0.54 per cent stake in Mumbai-headquartered Alkem Laboratories. The shares ...

The market closed moderately lower amid consolidation, but formed a bullish candlestick pattern on the daily charts, and the market breadth remained positive, given the continuation of buying ...

MUMBAI, India, Jan. 12, 2022 /PRNewswire/ -- Alkem Laboratories Ltd. (Alkem) hereby announces to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India.